节点文献
Effects of TanshinoneⅡA on the Myocardial Hypertrophy Signal Transduction System Protein Kinase B in Rats
【摘要】 <正>Objective:To study the effect of tanshinoneⅡA on the cell signal transduction system protein kinase B(Akt) in rats with hypertrophy of the myocardium induced by partial constriction of the thoracic aorta. Methods:Rat models of myocardial hypertrophy were established by the thoracic aorta partial constriction method. Forty-eight rats were randomly divided into the sham-operative group,the model group,the valsartan treatment group,and the low-,medium-,and high-dose tanshinone treatment groups.The heart mass index(HMI),left ventricular mass index(LVMI),ejection fraction(EF),left ventricular posterior wall(LVPW),and interventricular septal thickness(IVS) were detected by high-frequency ultrasonography.The myocardial fiber diameter(MFD) was detected by HE staining,and the contents of p-Akt and p-Gsk3βin the myocardium were detected by Western blot.Results:Compared with the sham-operative group,the levels of HMI,LVMI,LVPW,IVS,and MFD were increased respectively in the other groups(P<0.05);the contents of p-Akt and p-Gsk3βwere also increased in the other groups.Compared with the model group,the levels of HMI,LVMI,LVPW,IVS,and MFD were decreased respectively in all treatment groups(P<0.05);the contents of p-Akt and p-Gsk3βwere decreased in all treatment groups as well.There was no significant difference,however,among the low-,medium-,and high-dose tanshinone treatment groups and the valsartan treatment group(P>0.05).Conclusion:TanshinoneⅡA can prevent myocardial hypertrophy by its action on the protein kinase B(Akt) signaling pathway.
【Abstract】 Objective:To study the effect of tanshinoneⅡA on the cell signal transduction system protein kinase B(Akt) in rats with hypertrophy of the myocardium induced by partial constriction of the thoracic aorta. Methods:Rat models of myocardial hypertrophy were established by the thoracic aorta partial constriction method. Forty-eight rats were randomly divided into the sham-operative group,the model group,the valsartan treatment group,and the low-,medium-,and high-dose tanshinone treatment groups.The heart mass index(HMI),left ventricular mass index(LVMI),ejection fraction(EF),left ventricular posterior wall(LVPW),and interventricular septal thickness(IVS) were detected by high-frequency ultrasonography.The myocardial fiber diameter(MFD) was detected by HE staining,and the contents of p-Akt and p-Gsk3βin the myocardium were detected by Western blot.Results:Compared with the sham-operative group,the levels of HMI,LVMI,LVPW,IVS,and MFD were increased respectively in the other groups(P<0.05);the contents of p-Akt and p-Gsk3βwere also increased in the other groups.Compared with the model group,the levels of HMI,LVMI,LVPW,IVS,and MFD were decreased respectively in all treatment groups(P<0.05);the contents of p-Akt and p-Gsk3βwere decreased in all treatment groups as well.There was no significant difference,however,among the low-,medium-,and high-dose tanshinone treatment groups and the valsartan treatment group(P>0.05).Conclusion:TanshinoneⅡA can prevent myocardial hypertrophy by its action on the protein kinase B(Akt) signaling pathway.
【Key words】 tanshinoneⅡA; myocardial hypertrophy; rat; protein kinase B; thoracic aorta coarctation;
- 【文献出处】 Chinese Journal of Integrative Medicine ,中国结合医学杂志(英文版) , 编辑部邮箱 ,2009年05期
- 【分类号】R285
- 【被引频次】7
- 【下载频次】50